# Entrada Therapeutics, Inc.: Form SC 13D, filed Nov 12, 2021

- Company: [Entrada Therapeutics, Inc.](/companies/trda.md) (CIK 1689375)
- Form: SC 13D
- Filed: 2021-11-12
- Accepted by EDGAR: Nov 12, 2021, 16:30 ET
- Period: not reported
- Accession: 0001104659-21-138124
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1689375/000110465921138124/tm2132724d1_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1689375/000110465921138124/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1689375/000110465921138124/tm2132724d1_sc13d.htm

Filed Nov 12, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-138124. Last ingested by Listed: Nov 5, 2026, 11:57 ET. No prices; not investment advice.